Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial

Journal:
PLOS Medicine
Published:
DOI:
10.1371/journal.pmed.1004758
Affiliations:
10
Authors:
14
Go to article
Institutions Authors Share
Johns Hopkins University (JHU), United States of America (USA)
6.000000
 0.46
Rio de Janeiro Municipal Health Secretariat (SMS), Brazil
4.000000
 0.31
Tropical Medicine Foundation Doctor Heitor Vieira Dourado (FMT-HVD), Brazil
1.666667
 0.13
University of the State of Amazonas (UEA), Brazil
0.666667
 0.05
Federal University of Amazonas (UFAM), Brazil
0.333333
 0.03
Universidade Nilton Lins, Brazil
0.333333
 0.03
Interested in Clinical Sciences?